Global Cord Blood Corp (NYSE:CO) was the target of a significant decline in short interest in the month of August. As of August 15th, there was short interest totalling 260,700 shares, a decline of 24.6% from the July 15th total of 345,800 shares. Based on an average trading volume of 62,600 shares, the days-to-cover ratio is currently 4.2 days. Currently, 0.7% of the shares of the stock are sold short.
NYSE CO traded down $0.37 on Tuesday, reaching $4.60. The company’s stock had a trading volume of 227,820 shares, compared to its average volume of 63,949. The firm has a market cap of $670.96 million, a PE ratio of 15.77 and a beta of 0.20. The business has a 50-day moving average price of $5.62 and a 200 day moving average price of $6.42. Global Cord Blood has a 52 week low of $4.25 and a 52 week high of $7.73.
Global Cord Blood (NYSE:CO) last issued its quarterly earnings data on Tuesday, June 18th. The medical research company reported $0.11 earnings per share for the quarter. The firm had revenue of $37.50 million for the quarter. Global Cord Blood had a net margin of 29.56% and a return on equity of 8.84%.
Global Cord Blood Company Profile
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services.
Recommended Story: Return on Investment (ROI)
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.